PYRAZOLE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, MEDICINAL USE THEREOF, AND INTERMEDIATE FOR PRODUCTION THEREOF
A pyrazole derivative represented by the general formula (I) (wherein R1 is H, optionally substituted C1-6 alkyl, etc.; either of Q and T is the group of the formula (II) or the formula (III) and the other is optionally substituted C1-6 alkyl, etc.; R2 is H, halogeno, OH, optionally substituted C1-6...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Patent |
Sprache: | eng ; spa |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A pyrazole derivative represented by the general formula (I) (wherein R1 is H, optionally substituted C1-6 alkyl, etc.; either of Q and T is the group of the formula (II) or the formula (III) and the other is optionally substituted C1-6 alkyl, etc.; R2 is H, halogeno, OH, optionally substituted C1-6 alkyl, etc.; X is a single bond, O, or S; Y is a single bond, C1-6 alkylene, etc.; Z is CO or SO2; R4 and R5 each is H, optionally substituted C1-6 alkyl, etc.; and R3, R6, and R7 each is H, halogeno, etc.), a pharmacologically acceptable salt of the derivative, or a prodrug of either. They have excellent human SGLT1 inhibitory activity and are useful as a preventive or therapeutic agent for diseases attributable to hyperglycemia such as diabetes, complications of diabetes, and obesity.
Un derivado de pirazol representado por la formula general (1) (en donde R' es H, alquilo opcionalmente sustituido de 1 a 6 atomos de carbono, etc.; alguno entre Q y T es el grupo de la formula (II) o la formula (UI) y el otro es alquilo opcionalmente sustituido de 1 a 6 atomos de carbono, etc.; R2 es H, halogeno, OH, alquilo opcionalmente sustituido de 1 a 6 atomos de carbono, etc.; X es un enlace simple, O o S; Y es un enlace simple, alquileno de 1 a 5 atomos de carbono, etc.; Z es CO o SO2 R4 y R5 son cada uno II, alquilo opcionalmente sustituido de 1 a 6 atomos de carbono, etc.; y R3, R6, y R7 son cada uno II, halogeno, etc.), una sal farmacologicamente aceptable del derivado, o un profarmaco de cualquiera de ellos. Ellos tienen excelente actividad inhibitoria sobre el SGLTI humano y son utiles como un agente preventivo o terapeutico para enfermedades atribuibles a hiperglicemia, tales como diabetes, complicaciones de diabetes y obesidad. |
---|